I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Study objective is to compare the efficacy and safety of camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.
resectable osteosarcoma
psychotropic
hepatitis c
adriamycin
camrelizumab
- 0 views
- 19 Feb, 2024
ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities
In some sites they will consider the non-administration of MTP-PE or the non-administration of high doses of ifosfamide. And, in some hospitals, they will consider administering MTP-PE to all patients.
adjuvant therapy
tumor necrosis
ejection fraction
p-glycoprotein
adriamycin
- 0 views
- 19 Feb, 2024